Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities

Treatment of pediatric-onset multiple sclerosis (POMS) has been tailored after observational studies and data obtained from clinical trials in adult-onset multiple sclerosis (AOMS) patients. There are an increasing number of new therapeutic agents for AOMS, and many will be formally studied for use...

Full description

Bibliographic Details
Main Authors:	Monica Margoni, Francesca Rinaldi, Paola Perini, Paolo Gallo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Neurology
Subjects:	pediatric onset multiple sclerosis first-line therapies second-line therapies efficacy safety
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2021.676095/full

Similar Items

Irinotecan in the treatment of colorectal cancer. A literature review
by: V. A. Ivanov, et al.
Published: (2017-04-01)

Pediatric Onset Multiple Sclerosis and Obesity: Defining the Silhouette of Disease Features in Overweight Patients
by: Laura Papetti, et al.
Published: (2023-11-01)

Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
by: Hamdy SM, et al.
Published: (2018-02-01)

MRI-based diagnostic biomarkers for early onset pediatric multiple sclerosis
by: Martin Weygandt, et al.
Published: (2015-01-01)

Performance and Outcomes of Routine Viral Load Testing in People Living with HIV Newly Initiating ART in the Integrated HIV Care Program in Myanmar between January 2016 and December 2017
by: Sai Soe Thu Ya, et al.
Published: (2020-08-01)

Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
by: Sharon Del Vecchio, et al.
Published: (2018-10-01)

Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
by: Shigeki Yano, et al.
Published: (2023-11-01)

Glioblastoma treatment patterns, survival, and healthcare resource use in real-world clinical practice in the USA
by: Allicia C Girvan, et al.
Published: (2015-03-01)

How to Treat Hepatocellular Carcinoma in Elderly Patients
by: Piera Federico, et al.
Published: (2021-03-01)

The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series
by: Paolo Immovilli, et al.
Published: (2022-11-01)

Editorial: Disease modifying therapies in multiple sclerosis
by: Simona Bonavita, et al.
Published: (2022-08-01)

Multiple sclerosis in a 4-year-old boy: a case report and literature review
by: Ula Arkar, et al.
Published: (2024-03-01)

EXPERIENCE OF BEVACIZUMAB USE IN PATIENTS WITH INOPERABLE COLORECTAL CANCER IN KIROV REGION
by: N. Z. Sherman, et al.
Published: (2015-02-01)

A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern
by: Kathleen Kerrigan, DO, et al.
Published: (2022-03-01)

SESOTHO trial (“Switch Either near Suppression Or THOusand”) – switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa
by: Alain Amstutz, et al.
Published: (2018-02-01)

Mobile Attention Bias Modification Training Is a Digital Health Solution for Managing Distress in Multiple Sclerosis: A Pilot Study in Pediatric Onset
by: Leigh Charvet, et al.
Published: (2021-07-01)

Treatment failure and associated factors among first line patients on highly active antiretroviral therapy in Ethiopia: a systematic review and meta-analysis
by: Moges Agazhe Assemie, et al.
Published: (2019-10-01)

Pediatric immune thrombocytopenia: a focus on eltrombopag as second-line therapy
by: Giuseppe Palumbo, et al.
Published: (2023-12-01)

Factors associated with the efficiency of maintenance therapy in patients with metastatic colorectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2016-08-01)

Long-term virological outcome in children receiving first-line antiretroviral therapy
by: Padmapriyadarsini Chandrasekaran, et al.
Published: (2018-11-01)

Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)
by: Feng J, et al.
Published: (2019-11-01)

First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison
by: Mahn R, et al.
Published: (2024-01-01)

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
by: Eva Agnes Odongpiny Laker, et al.
Published: (2019-03-01)

Trend of antitubercular drug sensitivity test at a multispecialty hospital in Western India - A Retrospective Analysis
by: Shishir Jain, et al.
Published: (2020-01-01)

Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION): a multicenter, open-label, single-arm, phase 2 trialResearch in context
by: Reiko Matsuzawa, et al.
Published: (2023-12-01)

Current Advances in Pediatric Onset Multiple Sclerosis
by: Kristen S. Fisher, et al.
Published: (2020-03-01)

Efficacy and safety of anlotinib plus XELOX regimen as first-line therapy for mCRC: a single-arm, multicenter, phase II study (ALTER-C-001)
by: Bo Song, et al.
Published: (2023-09-01)

Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents
by: M. D. Bogdanova, et al.
Published: (2020-08-01)

Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis
by: Omid Mirmosayyeb, et al.
Published: (2020-05-01)

Effects of Acetaminophen Exposure on Outcomes of Patients Receiving Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
by: Fabrizio Nelli, et al.
Published: (2023-09-01)

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset
by: Chunrong Tao, et al.
Published: (2018-06-01)

Clinical example of long-term control of disseminated signet-ring cell carcinoma of the stomach against the background of chemotherapy of the second line of treatment in combination with bevacizumab
by: T. A. Titova, et al.
Published: (2019-12-01)

Dolutegravir for second-line treatment: Programmatic implications of new evidence
by: Ying Zhao, et al.
Published: (2022-09-01)

Clinical Observation of Erlotinib as the First-line Treatment for Patients with Advanced Non-small Cell Lung Cancer
by: Yunjian HUANG, et al.
Published: (2009-12-01)

Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study
by: Sabin Nsanzimana, et al.
Published: (2019-04-01)

Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple Sclerosis
by: Alessandra Logoteta, et al.
Published: (2023-03-01)

Microbiomes and Pediatric onset multiple sclerosis (MS): A systematic review
by: Sanaz Mehrabani, et al.
Published: (2023-12-01)

First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma
by: Xuechen Wang, et al.
Published: (2021-12-01)

European Registry on <em>Helicobacter pylori</em> Management: Effectiveness of First and Second-Line Treatment in Spain
by: María Caldas, et al.
Published: (2020-12-01)

Multiple Sclerosis—Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics
by: Claudia Mandato, et al.
Published: (2023-06-01)